Allogeneic hematopoietic cell transplantation (allo-HCT) for acute myeloid leukemia - prognostic factors and outcome

被引：0
|
作者：
Sakellari, I
Fassas, A
Yannaki, E
Saloum, R
Lalayanni, C
Batsis, I
Stamatopoulos, K
Eglezou, E
Kontodimou, A
Anagnostopoulos, A
机构：
来源：
BONE MARROW TRANSPLANTATION | 2003年 / 31卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S177 / S177
页数：1
相关论文
共 50 条
  • [1] ABO incompatibility has no effect on the outcome of allogeneic hematopoietic cell transplantation (allo-HCT)
    Sakellari, I
    Stavroylanni, N
    Kalogiannidis, P
    Marantidou, M
    Ganidou, M
    Natse, T
    Batsis, I
    Anagnostopoulos, A
    Fassas, A
    BONE MARROW TRANSPLANTATION, 2002, 29 : S115 - S115
  • [2] Effectiveness of allogeneic hematopoietic stem cell transplantation (allo-HCT) in patients transplanted with active myeloid disease
    Liga, Maria
    Spyridis, Nikolaos
    Triantafyllou, Evi
    Marangos, Markos
    Spyridonidis, Alexandros
    BONE MARROW TRANSPLANTATION, 2018, 53 : 495 - 496
  • [3] Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) for Treatment of Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (ALL)
    Burke, Michael
    Trotz, Barb
    Cao, Qing
    Weigel, Brenda
    Kumar, Ashish
    Smith, Angela
    Verneris, Michael
    BLOOD, 2009, 114 (22) : 1311 - 1311
  • [4] Early Hepatotoxicity in Patients with Myelofibrosis after Allogeneic Hematopoietic Cell Transplantation (Allo-HCT)
    Robin, Marie
    Gras, Luuk
    Gagelmann, Nico
    Koster, Linda
    de Latour, Regis Peffault
    Van Gorkom, Gwendolyn
    Ganser, Arnold
    Itala-Remes, Maija
    Zuckerman, Tsila
    Beguin, Yves
    Schaap, Nicolaas
    Drozd-Sokolowska, Joanna
    Raj, Kavita
    Hayden, Patrick J.
    de Wreede, Liesbeth C.
    Czerw, Tomasz
    Hernandez Boluda, Juan Carlos
    Kroeger, Nicolaus
    Yakoub-agha, Ibrahim
    McLornan, Donal P.
    BLOOD, 2022, 140 : 7585 - 7586
  • [5] Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) in Patients with Calr-Mutated Myelofibrosis
    Boluda, Juan Carlos Hernandez
    Eikema, Dirk-Jan
    Erazo, Nadia
    Kroeger, Nicolaus
    Robin, Marie
    de Witte, Moniek
    Finke, Juergen
    Rambaldi, Alessandro
    Broers, Annoek E. C.
    Raida, Ludek
    Schaap, Nicolaas
    Chiusolo, Patrizia
    Verbeek, Mareike
    Choi, Goda
    Halaburda, Kazimierz
    Kulagin, Alexander D.
    Labussiere-Wallet, Helene
    Gedde-Dahl, Tobias
    Rabitsch, Werner
    Raj, Kavita
    Drozd-Sokolowska, Joanna
    Polverelli, Nicola
    Czerw, Tomasz
    Yakoub-Agha, Ibrahim
    McLornan, Donal P.
    BLOOD, 2022, 140 : 10608 - 10610
  • [6] Cardiac events after allo-HCT in patients with acute myeloid leukemia
    Salas, Maria Queralt
    Cascos, Enric
    Lopez-Garcia, Alberto
    Perez, Estefania
    Baile-Gonzalez, Monica
    Rodriguez, Carlos Martin
    Cascon, Maria Jesus Pascual
    Luque, Marta
    Esquirol, Albert
    Fernando, Inmaculada Heras
    Pena-Munoz, Felipe
    Ormtegi, Itziar Oiartzabal
    Marin, Adolfo Jesus Saez
    Fernandez-Luis, Sara
    Dominguez-Garcia, Juan Jose
    Fernandez, Sara Villar
    Giron, Miguel Fernandez de Sanmamed
    Pinedo, Leslie Gonzalez
    Garcia, Lucia
    Gonzalez-Rodriguez, Ana Pilar
    Torrado, Tamara
    Filaferro, Silvia
    Cedillo, Angel
    Orti, Guillermo
    Chacon, Manuel Jurado
    BLOOD ADVANCES, 2024, 8 (21) : 5497 - 5509
  • [7] Outcome and Prognostic Factors of High-Risk Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation
    Zhu, Cheng-ying
    Chen, Guo-feng
    Zhou, Wei
    Hou, Cheng
    Wang, Xiao-kai
    Wang, Fei-yan
    Yang, Nan
    Wang, Li
    Fang, Shu
    Luo, Lan
    Guan, Li-xun
    Zhang, Ran
    Liu, Yu-chen
    Dou, Li-ping
    Gao, Chun-ji
    ANNALS OF TRANSPLANTATION, 2019, 24 : 328 - 340
  • [8] Risk Factors for 30-Day Hospital Readmission following Myeloablative Allogeneic Hematopoietic Cell Transplantation (allo-HCT)
    Bejanyan, Nelli
    Bolwell, Brian J.
    Lazaryan, Aleksandr
    Rybicki, Lisa
    Tench, Shawnda
    Duong, Hien
    Andresen, Steven
    Sobecks, Ronald
    Dean, Robert
    Pohlman, Brad
    Kalaycio, Matt
    Copelan, Edward A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (06) : 874 - 880
  • [9] Allogeneic Hematopoietic Cell Transplantation (allo-HCT) in T-Cell Prolymphocytic Leukemia (T-PLL): An Analysis from the CIBMTR
    Murthy, Hemant S.
    Ahn, Kwang Woo
    Estrada-Merly, Noel
    Gowda, Lohith
    Dholaria, Bhagirathbhai
    Bal, Susan
    Alkhateeb, Hassan B.
    Jagadeesh, Deepa
    Oran, Betul
    Nakamura, Ryotaro
    Scott, Bart L.
    Sauter, Craig S.
    Foss, Francine M.
    Kharfan-Dabaja, Mohamed A.
    Saber, Wael
    BLOOD, 2020, 136
  • [10] Cardiac risks of imatinib in chronic myelogenous leukemia (CML) patients who receive allogeneic hematopoietic cell transplantation (Allo-HCT)
    Burke, M. J.
    Gursahaney, A.
    Trotz, B.
    Luo, X.
    Baker, K. S.
    Weisdorf, D. J.
    Wagner, J. E.
    Michael, V. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345